Abstracts

NEONATAL ART < 7 DAYS VS 7-28 DAYS REDUCED TIME TO SUPPRESSION

Early antiretroviral therapy (ART) in children is associated with better clinical and virological outcome. Few data are available about long-term outcome of children starting ART in the neonatal period. Our hypothesis is that HIV-perinatally infected neonates initiating ART within <7 days of life have a better long-term clinical and virological response than neonates treated ≥7…

SAFETY AND PHARMACOKINETICS OF MONOCLONAL ANTIBODY, VRC01LS, IN HIV-EXPOSED NEWBORNS

Vertical HIV transmission occurs despite use of antiretroviral therapy (ART). A broadly neutralizing monoclonal antibody, administered to HIV-exposed infants might further prevent transmission. VRC01LS, modified from VRC01, has an extended half-life and may be a feasible adjunct to ART prophylaxis.   This is an open label safety and pharmacokinetic study of VRC01LS administered to HIV-exposed…

EXPANDING TESTING STRATEGIES IN PARIS: A FREE POSTAL COMPREHENSIVE STI TEST KIT

Testing is critical to HIV and other sexually transmitted infections (STI) treatment and prevention. The MemoDepistages multicenter study is a novel French government-based comprehensive STI testing program, providing free postal self-sampling kits to high-risk MSM. We present here the baseline results from the Paris area, accounting for 60% of all participants.   The program was…

DOUBLE-DOSE LEVONORGESTREL IMPLANT DOES NOT FULLY OVERCOME INTERACTION WITH EFAVIRENZ

We previously described 57% lower levonorgestrel (LNG) exposure in women receiving the LNG subdermal implant (standard dose, 150mg) with efavirenz (EFV)-based antiretroviral therapy (ART) compared to ART-naïve women. Three of 20 women (15%) had an unintended pregnancy within 48 weeks of LNG-EFV combined use, with observed LNG concentrations ≤303 pg/mL at the visit prior to…

POINT-OF-CARE VIRAL LOAD TESTING IMPROVES HIV VIRAL SUPPRESSION AND RETENTION IN CARE

Achieving the 90-90-90 targets will require efficient methods to monitor people living with HIV (PLHIV) on antiretroviral therapy (ART) in resource-limited settings. We compared point-of-care (POC) viral load (VL) testing to standard laboratory VL testing for achieving VL suppression and retention in care for PLHIV in Durban, South Africa.   We conducted an open-label, randomized…